Barbara Murphy, MD
Medical Oncology · Nashville, TNNPI 1285733618
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $29,075 of the $31,209 with a category attached, or 93.2%. 5 manufacturers reported payments, led by Merck at 48.6% of the total. Reporting peaked in 2020 at $15,431 and has fallen 99.6% since, to $65 in 2025.
Across 28 payments — averaging $1114.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$15K
- Amgen$9K
- Tactile Systems Technology Inc$4K
- Regeneron Healthcare Solutions, Inc.$3K
- EMD Serono, Inc.$67
Across 63 payments — averaging $12,435 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Tactile Systems Technology Inc$779K
- Siemens Medical Solutions USA, Inc.$4K
What the payments were for
- Consulting fees$29,07593%
- Travel & lodging$1,3674%
- Food & beverage$7672%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 16 | $15,181 |
| Amgen | 3 | $8,800 |
| Tactile Systems Technology Inc | 7 | $3,885 |
| Regeneron Healthcare Solutions, Inc. | 1 | $3,275 |
| EMD Serono, Inc. | 1 | $67 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nplate$8,800
- FLEXITOUCH$3,500
- ACTITOUCH$3,500
- ENTRE$3,500
- LIBTAYO$3,275
How this compares
$31,209 in reported general payments places this provider in the 70th percentile of 101 medical oncology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LenvimaLenvatinib Mesylate | 20 | $452,635 |
| Xtampza ErOxycodone Myristate | 32 | $100,774 |
| OxycontinOxycodone Hcl | 35 | $73,205 |
| Oxycodone Hcl | 232 | $13,254 |
| Fentanyl | 44 | $12,299 |
| EliquisApixaban | 12 | $11,484 |
| Gabapentin | 193 | $5,667 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 44 | $2,616 |
| Pentoxifylline | 20 | $1,824 |
| Morphine Sulfate ErMorphine Sulfate | 38 | $1,785 |
| Ondansetron Hcl | 35 | $1,366 |
| Lidocaine | 22 | $1,328 |
| Hydromorphone Hcl | 16 | $1,172 |
| Pilocarpine Hcl | 19 | $961 |
| Naloxone Hcl | 18 | $955 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in Nashville
- William PaoNashville$838K
- Dana ThompsonNashville$339K
- Robert RamirezNashville$321K
- Mace RothenbergNashville$318K
- Melissa JohnsonNashville$290K
- Cathy EngNashville$231K
- David SpigelNashville$167K
- Michael GibsonNashville$141K
- Jordan BerlinNashville$120K
- Vandana AbramsonNashville$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.